Nurix Therapeutics Q4 EPS $(0.87) Misses $(0.79) Estimate

Nurix Therapeutics (NASDAQ:NRIX) reported quarterly losses of $(0.87) per share which missed the analyst consensus estimate of $(0.79) by 10.13 percent. This is a 2.35 percent decrease over losses of $(0.85) per share

Nurix Therapeutics (NASDAQ:NRIX) reported quarterly losses of $(0.87) per share which missed the analyst consensus estimate of $(0.79) by 10.13 percent. This is a 2.35 percent decrease over losses of $(0.85) per share from the same period last year.

Total
0
Shares
Related Posts